Maximizing the potential AI/data-driven model of drug discovery requires the tec...
In exchange for $285 million, Copenhagen-based Ascendis has agreed to help Novo ...
AstraZeneca announced that its new weight-loss medication, which was licensed fr...
Roche first entered into an agreement with Orionis Biosciences in 2023 and paid ...
AbbVie has agreed to spend $1.4 billion to purchase Aliada Therapeutics. Through...
Izervay by Astellas and Syfovre by Apellis are the major rivals in the United St...
Apellis Pharmaceuticals and Novartis recently shared data for their rare kidney ...
A mid-phase trial featuring Gilead Sciences and Merck & Co.’s once-weekly HIV co...
The latest research on Arcus Biosciences’ experimental HIF-2a inhibitor suggests...
Marinus Pharmaceuticals, a pharmaceutical company, has been dealt a blow after i...
Two early-phase study trials suggest that GSK’s RSV vaccine, Arexvy, may benefit...
Common conditions in women such as PCOS, menopause, and endometriosis often lead...
Novartis is investing over $70 million in Chengdu Baiyu Pharmaceutical to bolste...
The Food and Drug Administration (FDA) has recently granted approval to Swiss co...
After last year’s Nobel Prize in Physiology or Medicine was awarded to Drew Weis...
A large phase 3 study conducted over GSK’s RSV vaccine Arexvy has shown how the ...
